#Denmark #Copenhagen #digital health #SaaS #Dawn Health

Dawn Health Secures Significant Funding to Expand Digital Health Solutions

In an exciting development for the digital health landscape, Dawn Health has successfully raised €11.5 million in funding aimed at further developing its platform and product range specifically designed for next-generation pharmaceutical digital health solutions. This funding round sees contributions from notable investors, including Chr. Augustinus Fabrikker, the Danish Export and Investment Fund (EIFO), and Trifork.

The investment is set to bolster Dawn Health's strategy of offering its expansive platform and product suite to international pharmaceutical companies through a Software as a Service (SaaS) model. This initiative is not only a testament to Dawn Health's innovative approach but also indicative of the increasing demand for sophisticated digital health solutions across the healthcare spectrum.

Since its inception in 2021, Dawn Health has concentrated its efforts on creating a premier platform uniquely tailored to address the challenges and use cases prevalent within the pharmaceutical industry. The platform and product suite from Dawn Health have already witnessed significant adoption among global industry leaders, including renowned names such as Merck and Novartis. This widespread adoption highlights the platform's applicability in critical healthcare areas such as oncology, multiple sclerosis, and rare pediatric diseases like growth disorders, thereby assisting patients in effectively managing their treatments, reporting symptoms, and maintaining close communication with their healthcare teams.

Dawn's platform and product offering are ground-breaking in their ability to enhance patient outcomes and healthcare delivery. By leveraging advanced capabilities in artificial intelligence, data analytics, evidence generation, clinical integrations, and personalization, it serves as a vital tool for pharmaceutical companies, patients, and healthcare professionals alike. This integration of technology significantly improves both data collection and analysis, which ultimately benefits both patients and pharmaceutical enterprises, establishing the Dawn platform as an essential component for therapeutic support tools, disease management programs, and data-driven real-world solutions that represent the next wave of digital health advances.

Alexander Mandix Hansen, CEO of Dawn Health, expressed the company's ambition, stating, "Our goal is to become the global leader in digital health technology, fueling next-generation pharmaceutical products and, ultimately, enhancing the lives of patients worldwide. This funding enables us to extend our proven platform into more markets and deepen our impact."

This recent milestone underscores Dawn Health's commitment to providing high-quality, scalable digital health products that meet the modern medicine landscape's regulatory demands. Furthermore, it emphasizes their role as a trusted partner for pharmaceutical companies.

According to Lars Marcher, the Chairman of Dawn Health, this funding will enable acceleration of their growth trajectory: "Since our significant investment in December 2021, we have seen substantial revenue growth and expanded our footprint within the global pharmaceutical sector. With over 100 employees, distinctive solutions, and a solid regulatory framework, we are well-positioned to accelerate our growth even further."

About Dawn Health

Dawn Health is a premier player in the digital health industry, focusing on developing software as medical devices (SaMD), digital therapeutic solutions (DTx), and connected health technologies. By rapidly bringing digital solutions to market, Dawn Health’s product suite fosters innovation that makes a transformative impact on the lives of individuals battling chronic health conditions. Collaborating closely with the life sciences sector, the company is dedicated to creating digital health products that redefine patient care through a human-centered, empathetic approach.

For more information, visit Dawn Health